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. NEWS & VIEWS 
Liver transplants contribute to their own success 
Stowaway stem cells in liver contribute to immunological tolerance 
in patients receiving liver transplants (pages 198-203). 
Mutually reinforcing studies reported by 
Taniguchi et a/. ' in this issue of Nature 
Medicine and elsewhere by Murase et a/.' 
have provided impor tan t insights in to 
transplantation immunology. Both in-
vestigations show that pluripotent 
hematolymphopoietic stem cells reside 
in the liver of mature rodents, and by in-
ference in other organs. The c ruc ial 
evidence supporting this phenomenon is 
provided by th e reconstitution of 
supralethally irradiated mice (9 .5 Gy) 
with stern cells purified from adult 
mouse livers' and the rescue of irradiated 
rats by the direct expedient of liver trans-
plantation'. With e ither approach, all 
hematolymphopoietic lineages are re-
stored in the reCipients. 
Two historical contributions preceding 
these results are noteworthy, both also in-
volving supratethal irradiation of reCipi-
ents before transplantation. In the first 
report, Hays ct a/.' describe multilineage 
reconstitution in mice with cultured syn-
geneic hepatic non-paren ch ymal cells 
(NPCs) obtained from adult mouse liver. 
(Reconstitution was most marked when 
NPCs were cultured from regenerating 
liver.) More recently, Decker et a/. em phil-
sized the equivalence of reconstitution in 
reCipients tran splanted with cultured syn-
genei c liver NP s versus bone marrow 
cells . Usin g sophisticated contem porary 
technology, Ta niguchi et a/. have greatly 
extended these observations, showing 
that the frequ ency of pluripotent stem 
cells in the mouse liver is at lea -t half that 
in bone marrow and about five times that 
in peripheral blood. /\s few as 500 of 
these sorted cells isolated from the NP s 
of adult mouse liver allow full reconstitu-
tion of irradiated reCipients. 
The organ transplant experiments of 
Murase el al. provide congruent evidence 
that the liver contains pluripotent 
hemato poietic stem cells The multilin-
eage reconstitution and permanent 
survival follOwing orthotopic transpla n-
tation of thoroug hl y flushed livers to 
irradiated rat recipients is equivalent to 
that ohtai ned after transplant of 10" un-
altered syngeneiC bone marrow cells (f ig. 
J). Heterotop ic heart transplantation 
also has a significant effect on postirradi-
ation survival. Prolongation of surviva l is 
less dramatic than that seen after liver 
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transplant but is similar to that obtained 
with a suboptimal dose of donor bone 
marrow or a large blood transfusion (fig. 
1). The permanent hematopoie ti c recon-
stitution of one of the cardiac reCipients 
and prolongation of survival of four of 
the five others suggests that stem cells 
are present in other organs besides th e 
of host stem cells survive and persists 
despite patient preconditioning with 
supralethal cytoablative therapy'. 
The experiments of Tan iguchi et a/. and 
Murase ct al.have added substantial weight 
to the argument that the diffe ren ce he-
tween the chimerism produced by classical 
bone marrow tra nspla ntation and that 
produced by the migrating stem cells from 
transplant organs is purE'ly semantic. 
following either conventiona l organ (rig. 
2a) or bone marrow transplantation (fig. 
2b) , the quantitative disproportion of the 
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Fig. 1 Survival (days) of adult Lewis (LEW) rats after lethal irradiation (9.5 Gy) and syn-
geneic organ or bone marrow transplantation. The different numbers of unfractionated 
LEW bone marrow cells (0.5, 1.0, or 5.0 X 10') were used to identify the minimum num-
ber of bone marrow cells necessary for reconstitution. Three milliliters of blood is 20-25% 
of the rat blood volume. 
liver but in smaller numbers. 
Experiments of such simplicity and 
power have not been performed pre-
viously, presumably reflecting the 
entrenched belief that the hemato-
lymphopoietic stem cells of adults 
require a bone marrow microenviron-
ment to survive. This dogma came und er 
question when it was discovered in 1992 
that small numbers of donor leukocytes 
were present in the skin, lymph nodes, 
blood, and other locat ions of patients 
whose kidney or liver allografts had been 
functioning for up to 30 years"". The im-
plication was that donor stem cells 
present in the transplanted organs had 
migrated and surviv ed in the recipient. 
Although the most easily demonstrable 
donor leUkocy tes in organ transplant re-
Cipients are dendritic cells (DCs) , the 
presence of multiple lineages of donor 
origin has been confirmed after liver 
t ransplantation in both rats ' and mice". 
After conventional clinical bone marrow 
transplantation , the mirror-image situa-
tion often arises when a trace population 
coexisting donor and recipient leukocytes 
is enormollS . C erti1elcss, both circum-
stantial ani dire t evidence shows that th ' 
two cell populations reciprocall)' modulate 
immune re ponsiveness, including the in-
duction of mutual non reactivity (t'he two-
way paradigm; Fig. _ C, d), Tllis canceling 
effect ha been pos tulated to explain th e 
poor prognostie vlI lue of Hl.A matching 
before whOle-orga n transplantation , the 
rarity of \ HD afte r organ allografting 
procedures (including bowel and/or liv r 
transpl,lI1tation L and the characteristic 
cyril' (If immunologic criSis and resolution 
that- is retkcted in the clinical course of all 
organ recipien ts"" . 
The ev idence that has accumulated 
since 1992 regardin leukocyte chimerism 
in organ r cipients has revealed a connec-
tion be tween th e acceptance of organ 
allografts, and the acquired neonatal tol-
erance described in 1953 by Billingham, 
Brent, and Medawar '''. During the ensuing 
four deC<ldes, transplantation and toler-
anre ha ve been defined largel y in terms 
of a unidirectional immune reaction : 
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a One-way paradigm (organ) b One-way paradigm (bone marrow) 
c Two -way paradigm (organ) d Two-way paradigm (bone marrow) 
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Fig. 2 upper panels, One-way paradigm in which transplantation is conceived as involving a unidirectional immune reaction: host-
versus-graft (HVG) with whole-organ transplants (a) and graft-versus-host (GVH) with bone marrow transplants (b). lower panels, 
Two-way paradigm in which transplantation is seen as a bidirectional and mutually canceling immune reaction that is predominantly 
HVG with whOle-organ grafts (c), and predominantly GVH with bone marrow grafts (d) . 
host-versus-graft (HVG) following organ 
transplantation (Fig. 2a) and graft-versus-
host (GV H) after bone marrow transplan-
tation (Fig. .:}Jl. Overthrow of this 
one-way paradigm has depended in part 
on finding an ~xplan ation for perpe tua-
tion of the trace popula tion of donor 
leukocytes found in the organ recipients. 
Such an explanation has now been pro-
vided by the results of Taniguchi et (/1. and 
Murase et at. As has been postulated ear-
lier" , transplantation of the liver (and 
possibly any organ) involves, in essence, 
the coincidental transplantation of 
pluripotent bone marrow stem cells, 
which are capable of renewing all 
hematopoietic lineages. 
Numerous secondary questions arise 
from this concept. For example, how is 
the donor immune system assimilated 
into the larger immuno logic network of 
th e recipient with progressive develop-
ment of mutual nonreactivity (bidirec-
tional to lerance)? A protective umbre lla of 
164 
immunosuppression is usually needed to 
ensure su ce -sful engraftment. However, 
this may be a ni ' a temporary requirement 
in humans' and outbred dogs" and indeed 
immunosuppres. ion treatment may not 
be n c ssary at all in a significant percent-
age of pig liver recipien ts A ! Jnd in liver 
transplants betwee n several rat strain 
combinations". As first shown by Ca ine et 
al. " , stable recipients are toleran t to subse-
quent transplant with other donor tissues 
and organs. Mouse o rgan transplantation 
models have been especially valuable for 
studying mechanisms of tolerance, be-
cause liver allografts are spontaneously ac-
cepted with the vas t majority of strain 
combinations and kidney and hea rt 
allografts are accepted with it few strain 
combinations'. 
Using the mouse liver transplant 
model, Lu and Thomson et al." have al-
ready shown that the migrating donor 
hematopoietic stem cells from the allo-
graft quickly develop proliferative cellular 
oases particularly in the bone marrow 
a nd other lymphOid organ s, where pre-
sumably pluripotent and precursor s tem 
cells of donor and recipient o rigin coexist 
at various stages of differentiation. These 
microniduses a re thought to constitute a 
growth factor-rich microenvironment 
that is at least partly self-generated by se-
cretions from thl' coexisting community 
of donor and host leukocytes. Paracrine 
factors secreted by the parenchymal cells 
of the donor organ (o r by recipient or-
gans) may a lso contribute to successful 
coexistence. Ca nd ida te factors inc lude 
both conventional cytokines and growth 
factors not usually associated with hema-
tolymphopo iesis "'. Before the discovery 
of spontaneous chimerism, Ca ine et al."·17 
proposed that the secretion of soluble 
class I antigens (rather than growth fac-
tors ) by allograft hepatoc ytes was the 
fundamental explanation for hepatic 
tolerogenicity. After the recognition of 
chimerism, they postulated that class I 
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molecules are essential for the engraft-
ment of donor hematopoietic stem cells'". 
However, this would impl y that organ 
tolerogenicity is a unique attribute of the 
liver. Instead, it is clear that the most im-
portant determinants for the successful 
establishment of spontaneous chimerism 
are the quantity and lineage profile of the 
leukocytes contained in the different 
transplanted organs, the liver being the 
most favorably endowed". 
A prominent donor leukocyte in both 
human and animal chimeric organ allo-
graft reCipients is the DC, which has 
been classically perceived as the most po-
tent of the antigen-presenting cells" and, 
therefore, presents an inherent barrier to 
successful transplantation. However, evi-
dence also exists for DC tolerogen-
icityl' ''. In the experiments of Lu et al. H, 
mice that spontaneously accepted liver 
allografts were found to have precursor 
donor-derived DCs that were deficient in 
the expression of costimulatory mole-
cules such as B7 and, therefore, were po-
tentially tolerogenic . In the liver 
recipients, the precursor cells persisted 
indefinitely in their disseminated loca-
tions within the reCipient, where they 
were admixed with recipient DCs under-
going the same Changes. Similar events 
follow heart transplantation but on a 
much smaller scale (summarized in ref. 
IS, 16). One product of the mutual cell 
engagement has been shown by 
Burlingham et al.'" to be a potent donor 
"veto" cell population in the blood of 
tolerant human kidney recipients. The 
I changes occurring at a molecular level 
and how such changes relate to T-cell ac-
tivation or unresponsiveness are still un-
resolved central issues in transplantation 
immunology. 
The clinical implications of this evolv-
ing concept of organ allograft acceptance 
via chimerism are obviOUS. The most di-
rect application is the augmentation of 
natural tolerogenic events by the adju-
vant administration of donor bone 
marrow, a strategy long advocated em-
pirically by Monaco et al.'1 long before it 
was realized that bone marrow cells were 
able to survive in the recipient. The pro· 
cedure now is under extensive clinical 
evaluation". In the future when and if 
xenotransplantation becomes a routine 
procedure, the gUiding principle of con-
trolled production of chimerism will be 
the same. 
The Pittsburgh Transplantation Institute 
Pittsburgh, Pennsylvania 15213, USA 
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A lesson from the HIV patient: 
The immune response is still the 
bane (or promise) of gene therapy 
The disappearance of genetically modified CTLs following infusion 
into AIDS patients led to a surprising observation: What are the 
implications for active immunotherapy (pages 216-223)? 
Among the prominent ob- ... ....... ....... ..................... tive individuals with genet-
stacles hampering progress Scon KOENIG ically modified gag-specific 
in human genetic modifi- CTLs, Their data provide 
cation is the ability of the immune evidence that a major obstacle to the 
system to eliminate genetically altered maintenance of genetically modified 
cells', Indeed, investigators are attempt- cells is the generation of specific immune 
ing to exploit the specific immunity responses, particularly those mediated by 
induced to gene-modified cells as thera- MHC class I-restricted CTLs. 
pies for cancer and chronic infectious 
diseases using vector systems originally 
designed for replacing or correcting de-
fective human genes', Riddell and 
colleagues' previously reported the pre-
vention of human cytomegalOVirus 
(HCMV) infection in bone marrow trans-
plant recipients by adoptive transfer of 
cytotoxic T lymphocytes (CTLs). As an 
extenSion of this research, Riddell et ai,', 
in this issue of Nature Medicine, present 
the results of infusing six HIV -seroposi-
Gene-modified cells or their products 
have been studied in vivo primarily in im-
mune-compromised hosts, such as 
individuals with primary immunodefi-
ciency or those undergOing bone marrow 
transplantation and cancer chemother-
apy", The objective of many of these 
initial human experiments has been to 
determine whether cells transfected with 
genes encoding an antibiotic selection 
marker perSist in inoculated individuals. 
The results suggest that some of the 
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